Delphi Consensus Recommendations on Management of Dosing, Adverse Events, and Comorbidities in the Treatment of Idiopathic Pulmonary Fibrosis with Nintedanib.

Franck RahaghiJohn A BelperioJohn FitzgeraldMridu GulatiRobert HallowellKristin B HighlandTristan J HuieHyun J KimMartin KolbJoseph A LaskyBrian D SouthernJeffrey J SwigrisJoao A de Andrade

Published in: Clinical medicine insights. Circulatory, respiratory and pulmonary medicine (2021)

These consensus recommendations provide additional guidance on the appropriate management of IPF with nintedanib, for use alongside evidence-based literature and the prescribing information.

Keyphrases

idiopathic pulmonary fibrosis
clinical practice
interstitial lung disease
primary care
systematic review
emergency department
systemic sclerosis